BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37653101)

  • 1. An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma.
    Liu S; Hu Q; Xie Z; Chen S; Li Y; Quan N; Huang K; Li R; Fang L
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15589-15608. PubMed ID: 37653101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
    Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
    Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia.
    Ren M; Feng L; Zong R; Sun H
    World J Surg Oncol; 2023 Aug; 21(1):257. PubMed ID: 37605192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma.
    Xiao Z; Li J; Yu Q; Zhou T; Duan J; Yang Z; Liu C; Xu F
    Front Pharmacol; 2021; 12():778294. PubMed ID: 35002712
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and Verification of a novel cuproptosis- and immune-associated based prognostic genetic signature for pancreatic ductal adenocarcinoma.
    Xu X; Liang JH; Xu QC; Yin XY
    Clin Res Hepatol Gastroenterol; 2023 Mar; 47(3):102089. PubMed ID: 36707046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma.
    Chen D; Huang H; Zang L; Gao W; Zhu H; Yu X
    Front Immunol; 2021; 12():728062. PubMed ID: 34691034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Immune-Related Signatures Related to CD4+ T Cell Infiltration With Gene Co-Expression Network in Pancreatic Adenocarcinoma.
    Tan Z; Lei Y; Zhang B; Shi S; Liu J; Yu X; Xu J; Liang C
    Front Oncol; 2021; 11():674897. PubMed ID: 34367961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implications of an Autophagy-related Gene Signature in Pancreatic Ductal Adenocarcinoma.
    Liu WS; Feng YX; Li SN; Shao YJ; Wang K
    Am J Clin Oncol; 2022 Mar; 45(3):95-104. PubMed ID: 35195559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDHA is a prognostic biomarker on the immune response in pancreatic adenocarcinoma and associated with m6A modification.
    Tan Z; Liu J; Xu J; Zhang B; Yu X; Wang W; Liang C
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4853-4865. PubMed ID: 36269388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an Immune-Related BAT Signature for Predicting Adjuvant Chemotherapy Response and Overall Survival in Patients with Resected Ductal Adenocarcinoma of the Pancreas.
    Pu N; Chen Q; Yin H; Zhang J; Zhao G; Habib JR; Chen J; Yu J; Lou W; Wu W
    J Gastrointest Surg; 2022 Apr; 26(4):869-886. PubMed ID: 35059985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma.
    Wang D; Cui SP; Chen Q; Ren ZY; Lyu SC; Zhao X; Lang R
    BMC Cancer; 2023 Jun; 23(1):601. PubMed ID: 37386391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma.
    Li XQ; Yin SQ; Chen L; Tulamaiti A; Xiao SY; Zhang XL; Shi L; Miao XC; Yang Y; Xing X
    BMC Cancer; 2024 Jan; 24(1):116. PubMed ID: 38262966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma.
    Sun X; Song H; Sun X; Liao C; Wang G; Xu Y; Li L; Han Y; Xu C; Wang W; Cai S; Liang H; Yu H
    Cancer Invest; 2024 Mar; 42(3):226-242. PubMed ID: 38616304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma.
    Cai W; Bao W; Chen S; Yang Y; Li Y
    Cancer Cell Int; 2021 Dec; 21(1):698. PubMed ID: 34930261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 16. A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma.
    Zhou C; Zhao Y; Yin Y; Hu Z; Atyah M; Chen W; Meng Z; Mao H; Zhou Q; Tang W; Wang P; Li Z; Weng J; Bruns C; Popp M; Popp F; Dong Q; Ren N
    Int J Biol Sci; 2019; 15(11):2282-2295. PubMed ID: 31595147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
    Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
    Front Immunol; 2021; 12():690056. PubMed ID: 34335594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel refined pyroptosis and inflammasome-related genes signature for predicting prognosis and immune microenvironment in pancreatic ductal adenocarcinoma.
    Zuo J; Yi C; Chen Z; Zhou B; Yang T; Lin J
    Sci Rep; 2022 Nov; 12(1):18384. PubMed ID: 36319832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
    Han Y; Drobisch P; Krüger A; William D; Grützmann K; Böthig L; Polster H; Seifert L; Seifert AM; Distler M; Pecqueux M; Riediger C; Plodeck V; Nebelung H; Weber GF; Pilarsky C; Kahlert U; Hinz U; Roth S; Hackert T; Weitz J; Wong FC; Kahlert C
    J Hematol Oncol; 2023 Feb; 16(1):7. PubMed ID: 36737824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.
    Liu X; Ren B; Fang Y; Ren J; Wang X; Gu M; Zhou F; Xiao R; Luo X; You L; Zhao Y
    J Transl Med; 2024 Apr; 22(1):393. PubMed ID: 38685045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.